IL107394A - Process for the preparation of metal complexes of tetraazacycloalkane derivatives - Google Patents

Process for the preparation of metal complexes of tetraazacycloalkane derivatives

Info

Publication number
IL107394A
IL107394A IL107394A IL10739493A IL107394A IL 107394 A IL107394 A IL 107394A IL 107394 A IL107394 A IL 107394A IL 10739493 A IL10739493 A IL 10739493A IL 107394 A IL107394 A IL 107394A
Authority
IL
Israel
Prior art keywords
optionally
tetraazacyclododecane
hydroxy
process according
group
Prior art date
Application number
IL107394A
Other versions
IL107394A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL107394A0 publication Critical patent/IL107394A0/en
Publication of IL107394A publication Critical patent/IL107394A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A novel process is described for the preparation of metal complexes of N- beta -hydroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-tetraazacyclo-dodecane and N- beta -hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraaza-cyclotetradecane derivatives.

Description

PROCESSES FOR THE PREPARATION OF METAL COMPLEXES TETRAAZACYCLOALKANE DERIVATIVES The invention relates to the process for the production of metal complexes, characterized in the claims, of N-/3-hydroxyalkyl-tri-N-carboxyalkyl-1 ,4,7, 10-tetraazacyclododecane and N-/3-hydroxyalkyl-tri-N-carboxyalkyl-l , 4 , 8 , 11-tetraazacyclotetradecane derivatives .
Because of their importance as imaging diagnostic agents (DE OS 36 25 417), especially NMR diagnostic agents, the production of metal complexes of N-?-hydroxyalkyl-tri-N-carboxyalkyl-1 , 4 , 7 , 10-tetraazacyclododecane and N-3-hydroxyalkyl-tri-N-carboxyalkyl-1 , 4,8, 11-tetraazacyclotetradecane derivatives has been tried in varied ways without a satisfactory method of synthesis, especially for their production on an industrial scale, previously having been able to be found.
In German laid-open specification DE 36 25 417 Al a process for the production of metal complexes of N substituted tri-N-carboxyalkyl-1 , 4 , 7 , 10-tetraazacyclododecane derivatives is described, in which tri-N-ethoxycarbonylmethyl-1 , 4 , 7 , 10-tetraazacyclododecane derivatives, that have a substitutent on the fourth nitrogen atom, are converted after cleavage of the still present carboxy protective groups into the metal complexes. The cyclic initial material needed for this process is obtained by specific ring synthesis. Thus a start is made from two reactants , which are cyclized according to methods known from the literature [e.g., Richman, Org. Synthesis 58, 86 (1978); Atkins, J. Amer. Chem. Soc. 96, 2268 (1974)]; one of the two reactants contains a protected nitrogen atom and carries on the chain end two leaving groups (e.g. , bromine, mesyloxy, tosyloxy, triflate or alkoxycarbonyl groups) that is nucleophilically displaced from the terminal nitrogen atoms of the second reactant of a — different from the first reactant — protected triaza compound.
The protective group chemistry used in the process of DE 36 25 417 Al always leads to additional reaction steps in which the protective group must be removed again.' Further large amounts of salts accumulate in the cleavage that then must be disposed of. Therefore an avoidance of protective groups, especially for a process that is to be used on an industrial scale, is desirable.
Tweedle et al. describe in European patent application 292 689 A7 and in publication Inorg. Chem. 1991, 30, 1265-1269 that starting from the unsubstituted macrocyclic compound 1,4,7,10-tetraazacyclododecane, the N-formyl compound can be obtained by a tricyclic intermediate stage. This compound still carrying three unprotected nitrogen atoms can now be trialkylated, deformylated and converted to the tetrasubstituted tetraazamacrocycle with haloacetic ester derivatives. After cleavage of the carboxy protective groups the tetrasubstituted complexing agent is obtained that can be reacted to the complex.
The synthesis method for the metal complexes described by Tweedle et al. for N substituted tri-N-carboxyalkyl-1 , 4 , 7 , 10-tetraazacyclododecane derivatives has not only the disadvantage of an unsatisfactorily high number of steps but it is not very suitable because of the high expenses for purification of the intermediate steps and high costs for large amounts of ion exchangers necessary for the production on an industrial scale. Further although a reaction of tri-N-carboxymethyl-1 , 4 , 7 , 10-tetraazacyclododecane (D03A, compound (2) in Inorg. Chem. Vol. 30, No. 6, 1991, 1267) with primary epoxides is possible, however, the yields for the reaction with secondary epoxides are clearly inferior and poorly suitable for use on an industrial scale .
Therefore it continues to be the object to make available a process for the production of metal complexes of N-?-hydroxyalkyl-tri-N-carboxyalkyl-1 ,4,7, 10-tetraazacyclododecane and N-y3-hydroxyalkyl-tri-N-carboxyalkyl-l, 4 , 8 , 11-tetraazacyclotetradecane derivatives, that as much as possible does not restrict the selection of the electrophiles needed in the process for the reaction and that above all is suitable for the reaction of sizable amounts of substance.
This object is achieved by this process.
It was found that the production of metal complexes of N-3-hydroxyalkyl-tri-N-carboxyalkyl-1, 4,7, 10-tetraazacyclododecane and- Ν-β-hydroxyalkyl-tri-N-carboxyalkyl-l, 4,8, 11-tetraazacyclotetradecane derivatives of general formula I 4 107,394/3 in which R1 means -CH2-COOY Y means hydrogen, a metal ion equivalent of an element of atomic numbers 21-32, 37-39, 42-51 or 57-83 provided that at least two substituents Y stand for metal equivalents n means the numbers 2 or 3 OH R2 means a CH-CH-R group R4 R4 and R5, independent of one another, each stand for a hydrogen atom, a ^-C20 ally1 radical optionally interrupted by 1 to 10 oxygen atom or atoms, a phenylene, phenylenoxy or phenylenedioxy group, which is optionally substituted by 1 to 3 C.-C6 alkyl, 1 to 3 trifluoromethyl, 1 to 7 hydroxy, 1 to 3 C^~C7 alkoxy or aralkoxy, 1 to 2 C02R6 radicals, in which R6 stands for a hydrogen atom, a C,-C6 alkyl group, a C6-C10 aryl or a c6-C10-Ar(C.-c4) alkyl group, and the optionally present hydroxy radicals optionally are present in protected form, as well as their salts with inorganic and/or organic bases, amino acids or amino acid amides, characterized in that the compound obtained from 1,4,7,10-tetraazacyclododecane or 1 , 4 , 8 , 11-tetraazacyclotetradecane general formula II in which n stands for the numbers 2 or 3 is reacted with an epoxide of general formula III in which R4 and R5 have the above-indicated meanings, and optionally present hydroxy or carboxy groups are optionally protected, to a intermediate of general formula IV in which R2 has the above-indicated meaning, and optionally present hydroxy groups and/or carboxy groups are optionally protected, the latter is saponified to an intermediate V (V), and the latter is reacted in the presence of a base with a compound of formula VI X-CH2-C00Z (VI), in which X means a leaving group Z means hydrogen, a carboxy protective group or a metal cation optionally after protection of hydroxy or carboxy groups in a polar solvent at -10°C to 170°C within 1-100 hours, the protecting groups are optionally cleaved off and the thus obtained complexing agent of formula VII (VII) is reacted with a metal oxide or metal salt of an element' of atomic numbers 21-32, 37-39, 42-51 or 57-83 and optionally still present hydrogen atoms are also substituted by cations of inorganic and/or organic bases, amino acids or amino acid amides or the still present acid groups are converted completely or partially into esters or amides.
The process according to the invention shows the following surprising effects: 1) The desired metal complexes of general formula (I) are obtained in a "one-pot reaction" under favorable operating conditions in higher yield than in the process of the prior art. 2) The intermediates are obtained in a so surprising high purity that their isolation and purification can be dispensed with. 3) In contrast with the process according to Tweedle et al. the reaction takes place with good yields even with secondary epoxides . 4) In comparison with the prior art, the process according to the invention comprises fewer steps. 5) The use of protective groups is indeed possible but not necessary for the process according to the invention.
• A process is preferred that is characterized in that a compound of formula (I) CO 8 107,394/2 in which ' R1 means -CH2-COOY Y means a metal ion equivalent of an element of atomic numbers 21-32, 37-39, 42-51 or 57-83 provided that at least two substituents Y stand for metal equivalents ri means the number 2 OH 2 CH-C1H- 5 Rz means a group R4 and R5, independent of one another, each stand for a hydrogen atom, a C.,-C10 alkyl radical optionally interrupted by 1 to 5 oxygen atom or atoms, a phenylene, phenylenoxy or phenylenedioxy group, which optionally is substituted by 1 to 3 C^-^ alkyl, 1 to 3 trifluoromethyl, 1 to 5 hydroxy, 1 to 3 C,-C7 alkoxy or 1 to 2 CO^L6 radicals , and R6 stands for a hydrogen atom, a C,-^ alkyl group or a benzyl group, is reacted.
Especially preferred is a process for the production of metal complexes of 10- (l-hydroxymethyl-2 , 3-dihydroxypropyl) - 1, 4 > 7-tris (carboxymethyl) -1, 4 , 7, 10-tetraazacyclododecane and of metal complexes of 10- (2-hydroxypropyl) -1, , 7- tris (carboxymethyl ) -1 , 4 , 7 , 10-tetraazacyclododecane .
Quite especially preferred is a process for the production of gadolinium or dysprosium complexes of 10- ( l-hydroxymethyl-2 , 3- dihydroxypropyl) -1 , 4 , 7-tris (carboxymethyl) -1,4,7,10- tetraazacyclododecane and gadolinium or dysprosium complexes of 10- (2-hydroxypropyl) -1,4, 7-tris (carboxymethyl) -1,4,7, 10-tetraazacyclododecane .
Preferred radicals R4 and R5 are the hydrogen atom, the methyl, ethyl, 2-hydroxyethyl , 2-hydroxy-l- (hydroxymethyl) ethyl , 1- (hydroxymethyl) ethyl , propyl, isopropyl, isopropenyl, 2-hydroxypropyl , 3-hydroxypropyl , 2,3-dihydroxypropyl , butyl , isobutyl, isobutenyl, 2-hydroxybutyl , 3-hydroxybuty1 , 4-hydroxybutyl , 2-hydroxy-2-methylbutyl , 3-hydroxy-2-methylbutyl , 4-hydroxy-2-methylbutyl , 2-hydroxyisobutyl , 3-hydroxyisobutyl , 2 , 3 , 4-trihydroxybutyl , 1 , 2 , 4-trihydroxybutyl , pentyl, cyclopentyl, 2-methoxyethyl , hexyl, decyl , tetradecyl , triethylene glycol methyl ether, tetraethylene glycol methyl ether and methoxvbenzyl group as well as the -CHj-O-C^H^-OH-, -CH2-0-C6H4-0- (CH2CH20) 2^CH3- , -CH2-0-C6H4-0-(CH2CH20)3-C5H11-/ -CH2-0-C6H4-0-C4Hs-OH- , -(CH2CH20)5-CH3-, -C^g-COOH-, -C9H18-OH-, • -CH2-0-C6H4-0-C6H12-COOH-, -CH2-0-C6H4-0-C4H8-0-CH2-CHOH-CH2OH- , - (CH2CK2-0) 3-C3H , -CH2-O-C10H20-COOH- , -CH2-0-C6H-Cl-, -CH2-0-C6H4-N02-, 107,394/2 -CH2-0-C6H3Cl2-, -CH2-0-C6H4-0-CH2-COOH- , -CH2-0-C6H4-0-CH2-COOH- and -CH2-0-C6H4-C5H group.
As alkoxy substituents in R4 and R5 are meant straight chain or branched radicals with 1 to 6 or 1 to 7 C atoms such as, for example, methoxy, ethoxy, propoxy, isopropoxy.
As alkyl groups R6 with 1-6 carbon atoms, straight chain or branched alkyl groups are suitable such as, for example, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert. -butyl.
Especially preferred are methyl, ethyl, tert. -butyl.
Preferred aryl groups and aralkyl groups R6 are phenyl, naphthyl and benzyl groups.
Especially preferred radicals R6 are hydrogen, the methyl radical or benzyl radical.
The tetraazatricyclotridecanes or pentadecanes of general formula II used as feedstocks are available according to methods known from the literature, in that 1 , 4 , 7 , 10-tetraazacyclododecane or 1, 4 , 8 , 11-tetraazacyclotetradecane is reacted with dimethylformamide dimethylacetale (U.S. Patents 4,085,106 and 4,130,715) .
Advantageously this reaction step is included in the process according to the invention.
Reaction conditions for the process steps 1) (II) + (III) → (IV) → (V) The reaction of the tricyclic intermediate step (II) with an epoxide of formula (III) takes place with or without solvent between 0°C and 220°C, preferably between room temperature and 210°C, within 1 to 48 hours, preferably from 5 to 12 hours, optionally at a pressure of up to 100 atm.
The reaction mixture containing compound (IV) , after cooling to -20°C to 80°C, preferably 0°C to 30°C, is mixed with a mixture of water/organic solvent, and stirred 0.5 to 12 hours, preferably 0.5 to 3 hours at -20°C to room temperature, preferably 0°C to room temperature.
By addition of an inorganic base or an acid at 0°C to 150°C, preferably room temperature to 120°C, within 1 to 72, preferably 6 to 24 hours, with stirring — optionally followed by subsequent protective group removal in a manner usual in the art — is reacted to the intermediate of formula V. The latter can also be isolated, if desired, as salt, preferably as hydrochloride.
As solvents for the reaction of the compounds of formula II with compounds of formula III, above all aprotic solvents such as, for example, benzene, tolene, dichloromethane, tetrahydrofuran, dioxane, acetonitrile, dimethylformamide, dimethylacetamide, di ethylsul foxide , hexane or diethylether are suitable.
The solvents used in the mixture with water can be, e.g., methanol, ethanol, isopropanol, tetrahydrofuran, dioxane.
As base or acid, for example, alkali and alkaline-earth hydroxides, alkali and alkaline-earth carbonates or mineral acids such as, e.g., hydrochloric acid or sulfuric acid or methane sulfonic acid are suitable. 2) (V) + (VI) → (VII) The bases added as acid traps in the further reaction of the intermediate of formula V with a compound of formula VI can be tertiary amines (e.g., triethylamine , trimethylamine , N,N-dimethylaminopyridine, 1 , 5-diazabicyclo [ 4.3.0 ] -non-5-ene (DBN) , 1 , 5-diazabicyclo [5.4.0] -undec-5-ene (DBU) , alkali or alkaline-earth carbonates, alkali or alkaline-earth bicarbonates , or alkali or alkaline-earth hydroxides (e.g., lithium-, sodium-, magnesium-, calcium-, barium-, potassium-, -carbonate, -hydroxide and -bicarbonate) .
The reaction takes place in polar solvents such as, for example, water, acetonitrile, dimethylformamide, dimethylsulfoxide, hexamethylphosphoric acid triamide or tetrahydrofuran as well as in alcohols with a chain length with up to 8 C atoms such as, e.g., methanol, ethanol, propanol , isopropanol, n-butanol, isobutanol, tert . -butanol .
The reaction is performed at temperatures of -10°C-170°C, preferably at 0°-120°C, especially preferred at 40°-100°C, within 0.5-48 hours, preferably 3-24 hours.
The optionally performed introduction or cleavage of protective groups of carboxyl- or hydroxy functions takes place according to methods known in the literature.
As acid protective groups lower alkyl-, aryl- and aralkyl groups, for example, methyl-, ethyl-, propyl-, n-butyl-, tert.-butyl-, phenyl-, benzyl-, diphenylmethyl- , triphenylmethyl-, bis (p-nitrophenyl ) -methyl groups, as well as trialkylsilyl groups are suitable.
The cleavage of the protective groups takes place according to processes known to one skilled in the art, for example, by hydrolysis, hydrogenolysis , alkaline saponification of the esters with alkali in aqueous alcoholic solution at temperatures of 0 to 50°C, acid saponification with mineral acids or in the case of e.g., tert. -butyl esters with the help of trifluoroacetic acid. As metal cations Z, metal cations of the elements of alkali or alkaline-earth metals are possible.
As hydroxy protective groups, e.g., benzyl-, 4-methoxybenzyl-, 4-nitrobenzyl- , trityl-, diphenylmethyl- , trimethylsilyl-, dimethyl-t-butylsilyl-, diphenyl-t-butylsilyl groups are suitable.
The hydroxy groups can also be present e.g., as THP-ether, a-alkoxyethylether, MEM-ether or as the esters with aromatic or aliphatic carboxylic acids, such as, e.g., acetic acid or benzoic acid. In the case of polyols, the hydroxy groups can also be protected in the form of ketals with, e.g., acetone, acetaldehyde, cyclohexanone or benzaldehyde .
The hydroxy protective groups can be released according to methods known from the literature to one skilled in the art, e.g., by hydrogenolysis, reductive cleavage with 1ithium/ammonia , acid treatment of the ethers and ketals or alkali treatment of the esters (see, e.g., "Protective Groups in Organic Synthetics", T.W. Greene, John Wiley and Sons 1981) .
The intermediately obtained complexing agents of formula VII can be purified in an advantageous way by ion exchangers. For this purpose especially cation exchangers (in the H+ form) which are first washed with water and then, eluted with aqueous ammonia solution, yield the desired product. IR 120 (H+) and AMB 252c (H+) as well as Reillex® have proven to be especially advantageous exchangers. If Reillex® is used the complexing agent is eluted with water or aqueous alcohols. 3) (VII) → (I) The production of the metal complexes according to formula I takes place in a way known in the art by the complexing agents of general formula VII being reacted with a metal oxide or metal salt of an element of atomic numbers 21-32, 37-39, 42-51 or .57-83 preferably in water and/or in aqueous solutions of lower alcohols (such as, e.g., methanol, ethanol or isopropanol) at temperatures of 20°C-110°C, preferably 80°C-100°C. The addition of 0.1-4 equivalents, preferably 0.5-2 equivalents, of an inorganic or organic acid, preferably acetic acid, has proved to be especially advantageous .
The thus obtained metal complex solutions can advantageously be purified by treatment on an ion exchange cascade or in a batch, consisting of an acid cation exchanger (H+ form) and basic anion exchanger (OH" form) , preferably IR 120 H+, AMB 252C/IRA 67.- The final cleaning is performed by crystallization from a lower alcohol, or an alcohol-water mixture. As alcohols there can be mentioned methanol, isopropanol, however ethanol is preferred.
The metal salts used can be, for example, nitrates, acetates, carbonates, chlorides or sulfates. The metals contained in the metal oxide or metal salt used can be an element of atomic numbers 21-32, 37-39, 42-51 or 57-83.
The following examples are used for detailed explanation of the object of the invention, however they are not to limit it. Example 1 Gadolinium complex of 10- (l-hydroxymethyl-2 , 3-dihydroxypropyl) -1,4, 7-tris (carboxymethyl) -1,4,7, 10-tetraazacyclododecane a) 20 1 (150.55 mol) of dimethylformamide dimethyl acetal is added (under nitrogen) to 20 kg (116.10 mol) of cyclene . (=1, 4 , 7, 10-tetraazacyclododecane) in 140 1 of toluene. It is slowly heated up and the azeotrope is distilled off from methanol/dimethylamine/toluene. Then, the solvent is completely distilled off by applying a vacuum. The remaining oil is allowed to cool to 50°C and then 18.7 kg (about 95%) (123.22 mol) . of 4,4-dimethyl-3 , 5 , 8-trioxabicyclo- (5.1.0) -octane is instilled (under nitrogen) . Then, it is stirred for 24 hours at 120°C. It is cooled to room temperature and a mixture of 100 1 of water/150 1 of methanol is instilled. Then, it is stirred for 1 hour at 50°C and 13.93 kg (348.3 mol) of sodium hydroxide is added. Then, it is refluxed for 8 hours. The solution is substantially evaporated to dryness, 200 1 of water is added and again about 100 1 of water is distilled off. Again, 100 1 of water is added and this solution is extracted once with 200 1 of n-butanol and then with 50 1 of n-butanol. The combined butanol phases are evaporated to dryness in a vacuum and the residue is taken up in 300 1 of water. Then, it is extracted twice with 50 1 of ethyl acetate each. The water phase is separated and concentrated by evaporation to a volume of about 200 1. b) 43.84 kg (464.4 mol) of chloroacetic acid is dissolved in 150 1 of water and adjusted to pH 7 with 50% aqueous sodium hydroxide solution. The water phase concentrated by evaporation to a volume of about 200 1 is added to this solution and heated to 80°C. The pH is kept between pH 9.5 - 10 by adding 50% aqueous sodium hydroxide solution. After 10 hours, another 10.96 kg (116.1 mol) of chloroacetic acid (previously neutralized as described above in 35 1 of water with 50% aqueous sodium hydroxide solution) is added. It is stirred for 12 hours at 80°C and the pH is kept between 9.5 and 10. It is allowed to cool to room temperature and adjusted with concentrated hydrochloric acid to pH 0.8. Then, it is stirred for 2 hours at 60°C. The solution is substantially evaporated to dryness in a vacuum. The residue is mixed twice with a mixture of 200 1 of methanol/200 1 of ethanol and evaporated to dryness. Then, the residue is absorptively precipitated for 1 hour at 50°C with 400 1 of methanol. It is filtered off from the precipitated sodium chloride, rewashed twice with 100 1 of methanol and the combined filtrates are evaporated to dryness in a vacuum. The residue is dissolved in 200 1 of water and added to an ion exchange column, filled with AMB 252c. It is washed with ample water and the product is eluted with a 10% aqueous ammonia solution. The product-containing fractions are substantially evaporated to dryness in a vacuum. c) The residue is dissolved in 200 1 of water and 16.31 kg (45 mol) of gadolinium oxide is added. It is refluxed for 3 hours. Then, 2 1 of glacial acetic acid is added and refluxed for another 2 hours. 5 kg of activated carbon is added and stirred for 1 hour at 90°C. The solution is filtered and the filtrate is added several times on an ion exchange column cascade (consisting of IRA 67 (OH" form)) AMB 252c (H* form) (under. HPLC control) . The eluate is concentrated by evaporation to a volume of 300 1 and stirred for 3 hours with 2 1 of acid ion exchanger IR 120 (H+) as well as basic exchanger IRA 67 (OH") each. It is filtered off from the exchanger and rewashed twice with 10 1 of water. 5 kg of activated carbon is added to the filtrate and stirred for 2 hours at 80°C. The solution is filtered and the filtrate is concentrated by evaporation in a vacuum. The residue is recrystallized from 95% aqueous ethanol (about 400 1) . The precipitate is suctioned off, rewashed twice with 80 1 of pure ethanol and dried for 48 hours at 70°C in a drying oven.
Yield: 47.6 kg (65.0% of theory) (corrected for water/ relative to cyclene) of colorless crystalline powder Water content: 4.1% Elementary analysis (relative to the anhydrous substance) : • Cld: C 35.75 H 5.17 N 9.27 Gd 26.00 Fnd: C 35.92 H 5.24 N 9.20 Gd 25.83 Example 2 Dysprosium complex of 10- [ l-hydroxymethyl-2 , 3-dihydroxypropyl ] -1,4, 7-tris (carboxymethyl) -1,4,7, 10-tetraazacyclododecane Analogously, the corresponding dysprosium complex can be produced if, instead of gadolinium oxide, correspondingly 16.78 kg (45 mol) of dysprosium oxide is reacted.
Yield: 46.36 kg (62.7% of theory) (corrected . for water/relative to cyclene) Water content: 3.9% Elementary analysis (relative to the anhydrous substance) : Cld: C 35.44 H 5.12 N 9.19 Dy 26.64 Fnd: C 35.35 H 5.21 N 9.11 Dy 26.57 Example 3 Gadolinium complex of 10- (2-hydroxypropyl) -1, 4 , 7-tris (carboxymethyl) -1,4,7, 10-tetraazacyclododecane a) 20 1 (150.55 mol) of dimethyl formamide dimethyl acetal is added (under nitrogen) to 20 kg (116.10 mol) of cyclene (=1, 4 , 7 , 10-tetraazacyclododecane) in 140 1 of toluene. It is slowly heated up and the azeotrope is distilled off from methanol/dimethylamine/toluene. Then, the solvent is completely distilled off by applying a vacuum. The remaining oil is allowed to cool to 50°C and then 10.11 kg (174.15 mol) of propylene oxide is instilled (under nitrogen) . Then, it is refluxed for 24 hours and then excess propylene oxide is distilled off in a vacuum. It is cooled to room temperature and a mixture of 100 1 of water/150 1 of methanol is instilled. Then, it is stirred for 1 hour at 50°C and 13.93 kg (348.3 mol) of sodium hydroxide is added.
Then, it is refluxed for 8 hours. The solution is substantially evaporated to dryness, 200 1 of water is added and again about 100 1 of water is distilled off. 100 1 of water is again added, and this solution is extracted once with 200 1 of n-butanol and then with 100 1 of n-butanol. The combined butanol phases are evaporated to dryness in a vacuum and the residue is taken up in 300 1 of water. Then, it is extracted twice with 50 1 of ethyl acetate each. The water phase is separated and concentrated by evaporation to a volume of about 200 1. b) 43.84 kg (464.4 mol) of chloroacetic acid is dissolved in 150 1 of water and adjusted to pH 7 with 50% aqueous sodium hydroxide solution. The water phase concentrated by evaporation to a volume of about 200 1 is added to this solution and heated to 80°C. The pH is kept between pH 9.5 - 10 by adding 50% aqueous sodium hydroxide solution. After 10 hours, another 10.96 kg (116.1 mol) of chloroacetic acid (previously neutralized as described above in 35 1 of water with 50% aqueous sodium hydroxide solution) is added. It is stirred for 12 hours at 80°C and the pH is kept between 9.5 and 10. It is allowed to cool to room temperature and adjusted with concentrated hydrochloric acid to pH 0.8. The solution is substantially evaporated to dryness in a vacuum. The residue is mixed twice with a mixture of 200 1 of methanol/200 1 of ethanol and evaporated to dryness. Then, the residue is absorptively precipitated for 1 hour at 50°C with 400 1 of methanol. It is filtered off from the precipitated sodium chloride, rewashed twice with 100 1 of methanol and the combined filtrates are evaporated to dryness in a vacuum. The residue is dissolved in 200 1 of water and added to an ion exchange column, filled with AMB 252c. It is washed with ample water and the product is eluted with a 10% aqueous ammonia solution. The product-containing fractions are substantially evaporated to dryness in a vacuum. c) The residue is dissolved in 200 1 of water and 17.62 kg (48.6 mol) of gadolinium oxide is added. It is refluxed for 3 hours. Then, 2 1 of glacial acetic acid is added and refluxed for another 2 hours. 5 kg of activated carbon is added and stirred for 1 hour at 90°C. The solution is filtered and the filtrate is added several times by an ion exchange column cascade (consisting of IRA 67 (OH" form) ) of AMB 252c (H+ form) (under HPLC control) . The eluate is concentrated by evaporation to a volume of 300 1 and stirred for 3 hours with 2 1 of acid ion exchanger IR 120 (H*) as well as basic exchanger IRA 67 (ΟΗ') each. It is filtered off from the exchanger and rewashed twice with 10 1 of water. 5 kg of activated carbon is added to the filtrate and stirred for 2 hours at 80°C. The solution is filtered and the filtrate is concentrated by evaporation in a vacuum. The residue is recrystallized from ethanol (about 300 1) .- The precipitate is suctioned off, rewashed once with 50 1 of pure ethanol and dried for 48 hours at 70°C in a drying oven.
Yield: 45.22 kg (67.2% of theory) (corrected for water/relative to cyclene) of colorless crystalline powder Water content: 3.5% Elementary analysis (relative to the anhydrous substance) : Cld: C 36.55 H 5.23 N 10.03 Gd 2S.15 Fnd: C 36.68 H 5.31 N 9.91 Gd 28.03 Example 4 Dysprosium complex of 10- (2-hydroxypropyl) -1, 4 , 7-tris (carboxymethyl) -1,4,7, 10-tetraazacyclododecane Analogous to example 3c) , the corresponding dysprosium complex can be produced, if, instead of gadolinium oxide, correspondingly 18.13 kg (48.6 mol) of dysprosium oxide is reacted.
Yield: 47.14 kg (65.3% of theory) (corrected for water/relative to cyclene) Water content: 4.1% Elementary analysis (relative to the anhydrous substance) : Cld: C 36.20 H 5.18 N 9.94 Dy 28.82 Fnd: C 36.32 H 5.27 N 9.87 Dy 28.69 Example 5 Gadolinium complex of 10- (2-hydroxy-3-methoxy-propyl) -1, 4 , 7-tris ( carboxymethyl ) -1 , 4 , 7 , 10-tetraazacyclododecane Analogously it can be reacted with 2,3-epoxypropyl ethylether instead of propylene oxide as described in example 3. Thus, for example, 216.7 g (61% of theory) of the title compound is obtained from 100 g (0.58 mol) of 1,4, 7, 10-tetraazacyclododecane as colorless powder (crystallization from aqueous acetone) .
Water content: 3.8% Elementary analysis (relative to the anhydrous substance) Cld: C 36.72 H 5.72 N 9.52 Gd 26.71 Fnd: C 36.51 H 5.83 N 9.39 Gd 26.57 Example 6 Gadolinium complex of 10- (2-hydroxy-3-benzyloxy-propyl) -1, 4 , 7-tris (carboxymethyl) -1,4,7, 10-tetraazacyclododecane Analogously it can be reacted with 2 , 3-epoxypropyl-benzylether instead of propylene oxide as described in example 1.1 equivalents of epoxide is used relative to 1, 4, 7, 10-tetraazacyclododecane . It is heated for 16 hours at 110°C (instead of 24 hours as described in example 3) . Thus 249.2 g (62% of theory) of the title compound is obtained from 100 g (0.58 mol) of 1 , 4 , 7 , 10-tetraazacyclododecane (crystallization from isopropanol) .
Water content: 4.2% Elementary analysis (relative to the anhydrous substance) Cld: C 43.36 H 5.31 N 8.43 Gd 23.65 Fnd: C 43.21 H 5.40 N 8.32 Gd 23.48 Example 7 Gadolinium complex of 10- (2 , 3 , 4-trihydroxybutyl) -1, 4 , 7-tris (carboxymethyl) -1,4,7, 10-tetraazacyclododecane Analogously it can be reacted with 2- ( 2 , 2-dimethyl-l , 3-dioxolan-4-yl) -ethylene oxide instead of 4 , 4-dimethyl-3 , 5 , 8-trioxabicyclo- ( 5.1.0) -octane as described in example 1. 1.1 equivalents of epoxide is used relative to 1,4,7,10- tetraazacyclododecane. It is heated for 16 hours at 110°C (instead of 24 hours as described in example 1). Thus 232.8 g (64% of theory) of the title compound is obtained as colorless, crystalline powder from 100 g (0.58 mol) of 1,4,7,10-tetraazacyclododecane (crystallization from 90% aqueous ethanol) . Water content: 3.5% Elementary analysis (relative to the anhydrous substance) : Cld: C 35.75 H 5.17 N 9.26 Gd 26.00 Fnd: C 35.55 H 5.23 N 9.14 Gd 25.87 Example 8 Gadolinium complex of 10- (2-hydroxy-3-tert . -butoxy-propyl) -1 , 4 , 7-tris (carboxymethyl) -1,4,7, 10-tetraazacyclododecane Analogously it can be reacted with 2 , 3-epoxypropyl-tert . -butyl ester instead of propylene oxide as described in example 3. 1.1 equivalents of epoxide is used relative to 1,4, 7, 10-tetraazacyclododecane. It is heated for 16 hours at 110°C (instead of 24 hours as described in example 3) . Thus 225 g (59% of theory) of the title compound is obtained as colorless, crystalline powder from 100 g (0.58 mol) of 1,4,7, 10-tetraazacyclododecane (crystallization from acetone/ethanol) .
Water content: 4.0% Elementary analysis (relative to the anhydrous substance) : Cld: C 39.99 H 5.91 N 8.88 Gd 24.93 Fnd: C 39.81 H 6.05 N 8.73 Gd 24.82 Example 9 Gadolinium complex of 10- (2 , 6 , 7-trihydroxy-4-oxaheptyl) -1 , 4 , 7-tris (carboxymethyl) -1,4,7, 10-tetraazacyclododecane Analogously it can be reacted with 2 , 2-dimethyl-4- ( 2 ' , 3 ' -epoxy) -propoxy-methyl-1, 3-dioxolane instead of 4 , 4-dimethyl-3 , 5 , 8-trioxabicyclo- (5.1.0) -octane as described in example 1. 1.1 equivalents of epoxide is used relative to 1,4 ,7, 10-tetraazacyclododecane. It is heated for 16 hours at 110°C (instead of 24 hours as described in example 1) . Thus 242.2 g (62% of theory) of the title compound is obtained as colorless, crystalline powder from 100 g (0.58 mol) of 1,4, 7, 10-tetraazacyclododecane (crystallization from ethanol) .
Water content: 3.6% Elementary analysis (relative to the anhydrous substance) : Cld: C 37.03 H 5.44 N 8.64 Gd 24.24 Fnd: C 36.91 H 5.58 N 8.49 Gd 24.13 Example 10 Gadolinium complex of 10- (2-hydroxy-3-isopropoxy-propyl) -1, 4 , 7-tris (carboxymethyl) -1,4,7, 10-tetraazacyclododecane Analogously it can be reacted with 2 , 3-epoxypropylisopropyl ether instead of propylene oxide as described in example 3. 1.1 equivalents of epoxide is used relative to 1,4,7, 10-tetraazacyclododecane. It is heated for 16 hours at 110°C (instead of 24 hours as described in example 3) . Thus 232.5 g (63% of theory) of the title compound is obtained as colorless, crystalline powder from 100 g (0.58 mol) of 1,4,7,10-tetraazacyclododecane (crystallization from isopropanol) .
Water content: 3.1% Elementary analysis (relative to the anhydrous substance) : Cld: C 38.95 H 5.72 N 9.08 Gd 25.50 Fnd: C 38.85 H 5.81 N 8.93 Gd 25.35 Example 11 Gadolinium complex of 10- (2-hydroxy-2-methyl-propyl) -1 , 4 , 7-tris (carboxymethyl) -1,4,7, 10-tetraazacyclododecane Analogously it can be reacted with iso-butylene oxide instead of propylene oxide as described in example 3. Thus for example 209.4 g (60% of theory) of the title compound is obtained as colorless powder from 100 g (0.58 mol) of 1,4, 7, 10-tetraazacyclododecane (crystallization from aqueous acetone) .
Water content: 4.0% Elementary analysis (relative to the anhydrous substance) : Cld: C 37.75 H 5.46 N 9.78 Gd 27.46 Fnd: C 37.61 H 5.53 N 9.70 . Gd 27.38 Example 12 Gadolinium complex of 10- (2-hydroxy-3-phenoxy-propyl) -1 , 4 , 7-tris (carboxymethyl) -1, 4,7, 10-tetraazacyclododecane Analogously it can be reacted with 2 , 3-epoxypropyl-phenyl ether instead of propylene oxide as described in example 3. 1.1 equivalents of epoxide is used relative to 1, 4, 7, 10-tetraazacyclododecane . It is heated for 16 hours at 110°C (instead of 24 hours as described in example 3). Thus 252.4 g (64% of theory) of the title compound is obtained as colorless, crystalline powder from 100 g (0.58 mol) of 1,4,7,10-tetraazacyclododecane (crystallization from aqueous acetone) .
Water content: 3.7% Elementary analysis (relative to the anhydrous substance) : Cld: C 43.49 H 5.02 N 8.45 Gd 23.73 Fnd: C 43.31 H 5.11 N 8.38 Gd 23.65

Claims (10)

Claims
1. Process for the production of metal complexes of N-/3-hydroxyalkyl-tri-N-carboxyalkyl-1 ,4,7, 10-tetraazacyclododecane and N-/3-hydroxyalkyl-tri-N-carboxyalkyl-l ,4,8,11-tetraazacyclotetradecane derivatives of general formula I in which R1 means -CH2-COOY Y means hydrogen, a metal ion equivalent of an element of atomic numbers 21-32, 37-39, 42-51 or 57-83 provided that at least two substituents Y stand for metal equivalents n means the numbers 2 or 3 OH R2 means a CH-CH-R group ' 4 R R4 and R5, independent of one another, each stand for a hydrogen atom, a ^-C^ alkyl radical optionally interrupted by 1 to 10 oxygen atom or atoms, a phenylene, phenylenoxy or phenylenedioxy group, which optionally is substituted by 1 to 3 107,394/2 C,-C6 alkyl, 1 to 3 trifluoromethyl , 1 to 7 hydroxy, 1 to 3 C,-C7 alkoxy or (C6-CTO) -ar- (C,-C4) alkoxy, 1 to 2 C02R6 radicals, R6 stands for a hydrogen atom, a C.-C6 alkyl group, a C6-C10 aryl or a C6-C10-Ar (C.-C4) alkyl group, and the optionally present hydroxy radicals optionally are present in protected form, as well as their salts with inorganic and/or organic bases, amino acids or amino acid amides characterized in that the compound obtained from 1,4,7,10-tetraazacyclododecane or 1, 4 , 8, 11-tetraazacyclotetradecane of general formula II (Π) in which n stands for the numbers 2 or 3 is reacted with an epoxide of general formula III 0 in which R and R5 have the above-indicated meaning, and optionally present hydroxy or carboxy groups are optionally protected, to a intermediate of general formula IV in which R2 has the above-indicated meaning, and optionally present hydroxy groups and/or carboxy groups are optionally protected, the latter is saponified to an intermediate V (V), and- the latter is reacted in the presence of an acid trap with a compound of formula VI X-CH2-COOZ (VI). in which X means a leaving group Z means hydrogen, a carboxy protective group or a metal cation optionally after protection of hydroxy or carboxy groups, optionally present in (V) in a polar solvent at -10°C to 170°C within 1-100 hours, the protecting groups are optionally cleaved off and the thus obtained complexing agent of formula VII is reacted with a metal oxide or metal salt of an element of atomic numbers 21-32, 37-39, 42-51 or 57-83 and optionally still present hydrogen atoms are substitued by cations of inorganic or organic bases, amino acids or amino acid amides or the still present acid groups are converted completely or partially into esters or amides.
2. Process according to claim 1, wherein the reaction to a compound of general formula (IV) takes place at a temperature between 20°C and 120°C without or in an aprotic solvent.
3. Process according to claim 1, wherein the reaction to a compound of general formula (V) takes place at temperatures between 20°C and 210°C in aqueous alcohols with addition of sodium hydroxide or potassium hydroxide or hydrochloric acid.
4. Process according to claim 1, wherein the compound of formula (VI) is chloroacetic acid. 31 107,394/2
5. Process according to claim 1, wherein the reaction to a compound of general formula (VII) takes place without protection of hydroxy or carboxy groups at temperatures between 40°C and · 100°C in water within 3-24 hours.
6. Process according to claim 1, wherein a compound of formula (I) in which R1 means -CH2-COOY Y means a metal ion equivalent of an element of atomic numbers 21-32, 37-39, 42-51 or 57-83 n means the number 2 OH R2 means a CH-CH-R group I 4 R R4 and R5, independent of one another, each stand for a hydrogen atom, a C.,-C10 alkyl radical optionally interrupted by 1 to -5 oxygen atom or atoms, a phenylene, phenylenoxy or phenylenedioxy group, which optionally is substituted by 1 to 3 C,-C6 alkyl, 1 to 3 trifluoromethyl, 1 to 5 hydroxy, 1 to 3 C^-C6 alkoxy or 1 to 2 C02R6 radicals, and R stands for a hydrogen atom, a C^-C^ alkyl group benzyl group, is reacted.
7. Process according to claim 1 for the production of metal complexes of 10- (l-hydroxymethyl-2 , 3-dihydroxypropyl) -1, 4 , 7-tris (carboxymethyl) -1,4,7, 10-tetraazacyclododecane .
8. Process according to claim 1 for the production of metal complexes of 10- (2-hydroxypropyl ) -1 , 4 , 7-tris (carboxymethyl) -1,4,7, 10-tetraazacyclododecane .
9. Process according to claim 1 for the production of gadolinium or dysprosium complexes of 10- ( l-hydroxymethyl-2 , 3-dihydroxypropyl) -1, 4 , 7-tris (carboxymethyl) -1,4,7, 10-tetraazacyclododecane.
10. Process according to claim 1 for the production of gadolinium or dysprosium complexes of 10- (2-hydroxypropyl) -1, 4 , 7-tris (carboxymethyl) -1,4,7, 10-tetraazacyclododecane . the Appl i cant WOLFF, BREGMAN GOLLER by : ^J
IL107394A 1992-11-06 1993-10-25 Process for the preparation of metal complexes of tetraazacycloalkane derivatives IL107394A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4237943A DE4237943C2 (en) 1992-11-06 1992-11-06 Process for the preparation of metal complexes of N-beta-hydroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-tetraazacyclododecane and N-beta-hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecane Derivatives

Publications (2)

Publication Number Publication Date
IL107394A0 IL107394A0 (en) 1994-01-25
IL107394A true IL107394A (en) 1998-06-15

Family

ID=6472539

Family Applications (1)

Application Number Title Priority Date Filing Date
IL107394A IL107394A (en) 1992-11-06 1993-10-25 Process for the preparation of metal complexes of tetraazacycloalkane derivatives

Country Status (13)

Country Link
EP (1) EP0596586B1 (en)
JP (1) JP3727359B2 (en)
AT (1) ATE148110T1 (en)
CA (1) CA2102461C (en)
CZ (1) CZ285411B6 (en)
DE (2) DE4237943C2 (en)
DK (1) DK0596586T3 (en)
ES (1) ES2099900T3 (en)
GR (1) GR3022866T3 (en)
HU (1) HU214014B (en)
IL (1) IL107394A (en)
NO (1) NO302174B1 (en)
SK (1) SK281285B6 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407435D0 (en) * 1994-04-14 1994-06-08 Nycomed Salutar Inc Compounds
DE19724186C2 (en) * 1997-06-02 2002-07-18 Schering Ag Process for the mono- and 1,7-bis-N-ß-hydroxyalkylation of cycles and the corresponding N-ß-hydroxyalkyl-1,4,7,10-tetraazacyclododecane-Li salt complexes
IT1292128B1 (en) * 1997-06-11 1999-01-25 Bracco Spa PROCESS FOR THE PREPARATION OF MACROCYCLIC CHELANTS AND THEIR CHELATES WITH PARAMAGNETIC METALLIC IONS
IT1292130B1 (en) * 1997-06-11 1999-01-25 Bracco Spa PROCESS FOR THE PREPARATION OF 1,4,7,10-TETRAAZACYCLODODECAN -1,4,7-TRIACETIC ACID AND ITS DERIVATIVES
DE102009053171B4 (en) 2009-11-04 2011-07-21 Bayer Schering Pharma Aktiengesellschaft, 13353 Process for the preparation of the calcium complex of dihydroxy-hydroxy-methylpropyl-tetraazacyclododecane-triacetic acid (Calcobutrol)
DE102009057274B4 (en) 2009-12-02 2011-09-01 Bayer Schering Pharma Aktiengesellschaft Gadobutrol preparation using trioxobicyclo-octane
EP2327395A1 (en) * 2009-11-23 2011-06-01 Bracco Imaging S.p.A Process for the preparation of gadobenate dimeglumine complex in a solid form
DE102010013833A1 (en) 2010-03-29 2011-09-29 Bayer Schering Pharma Aktiengesellschaft Producing gadolinium complex of N-(hydroxymethyl-dihydroxypropyl)-triscarboxymethyl-tetraazacyclododecane useful as magnetic resonance imaging contrast agent, comprises e.g. reacting cyclic compound with dimethylformamide dimethylacetal
DE102010023105A1 (en) 2010-06-04 2011-12-08 Bayer Schering Pharma Aktiengesellschaft Gadobutrol preparation in a one-pot process using DMF-acetal and N-methylimidazole
US9233971B2 (en) * 2010-08-26 2016-01-12 Kunyuan Cui Lipomacrocycles and uses thereof
NZ616637A (en) 2011-04-21 2016-01-29 Bayer Ip Gmbh Preparation of high-purity gadobutrol
KR101653064B1 (en) * 2014-12-26 2016-09-09 에스티팜 주식회사 A Method for Gadobutrol
SG11201901460UA (en) 2016-09-27 2019-03-28 Bayer Pharma AG Method for producing the crystalline form of modification a of calcobutrol
KR102033964B1 (en) * 2018-01-19 2019-10-18 주식회사 엔지켐생명과학 Gadoteridol intermediate and method for preparing gadoteridol using the same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
DE3625417C2 (en) * 1986-07-28 1998-10-08 Schering Ag Tetraazacyclododecane derivatives
EP0299795B1 (en) * 1987-07-16 1992-03-18 Nycomed As Aminopolycarboxylic acids and derivatives thereof
GB8719042D0 (en) * 1987-08-12 1987-09-16 Parker D Conjugate compounds
US4889931A (en) * 1988-09-27 1989-12-26 Salutar, Inc. Manganese (II) chelate manufacture
AU625529B2 (en) * 1989-12-22 1992-07-16 E.R. Squibb & Sons, Inc. 10-(2'-hydroxy-3'-alkoxy-1,4,7-triscarboxymethyl-1,4,7,10- tetraazacyclododecanes
AU6709390A (en) * 1989-12-22 1991-06-27 E.R. Squibb & Sons, Inc. 10-(2'-hydroxy-3'-polyoxaalkyl)-1,4,7-tris-carboxymethyl -1,4,7,10-tetraazacyclododecane
DE4009119A1 (en) * 1990-03-19 1991-09-26 Schering Ag 1,4,7,10-TETRAAZACYCLODODECANE-BUTYLTRIOLS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM
IT1243801B (en) * 1990-08-29 1994-06-28 Bracco Ind Chimica Spa INTERMEDIATES FOR CHELATING AGENTS WITH PRE-FIXED SYMMETRY, AND PROCEDURES FOR THEIR PREPARATION
DE4035760A1 (en) * 1990-11-08 1992-05-14 Schering Ag MONO-N-SUBSTITUTED 1,4,7,10-TETRAAZACYCLODODECAN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM
DE4115789A1 (en) * 1991-05-10 1992-11-12 Schering Ag MACROCYCLIC POLYMER COMPLEX IMAGERS, THEIR COMPLEXES, METHOD FOR THEIR PRODUCTION AND THE PHARMACEUTICAL AGENTS CONTAINING THEM
DE4140779A1 (en) * 1991-12-06 1993-06-09 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De METHOD FOR PRODUCING MONO-N SUBSTITUTED TETRAAZAMACROCYCLES

Also Published As

Publication number Publication date
JP3727359B2 (en) 2005-12-14
CZ237493A3 (en) 1994-10-19
DE59305238D1 (en) 1997-03-06
CZ285411B6 (en) 1999-08-11
GR3022866T3 (en) 1997-06-30
ES2099900T3 (en) 1997-06-01
IL107394A0 (en) 1994-01-25
SK281285B6 (en) 2001-02-12
NO934002L (en) 1994-05-09
DE4237943A1 (en) 1994-05-11
HU214014B (en) 1997-12-29
NO934002D0 (en) 1993-11-05
CA2102461C (en) 2005-01-25
HUT67583A (en) 1995-04-28
JPH06228115A (en) 1994-08-16
NO302174B1 (en) 1998-02-02
SK124193A3 (en) 1994-12-07
EP0596586B1 (en) 1997-01-22
DE4237943C2 (en) 1997-10-23
CA2102461A1 (en) 1994-05-07
DK0596586T3 (en) 1997-07-28
ATE148110T1 (en) 1997-02-15
EP0596586A1 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
CA2137243C (en) Process for the production of n-.beta.-hydroxyalkyl-tri-n-carboxyalkyl -1,4,7,10-tetraazacyclododecane and n-.beta.-hydroxyalkyl-tri-n-carboxyalkyl-1,4,8,11- tetraazacyclotetradecane derivatives and their metal compllexes
IL107394A (en) Process for the preparation of metal complexes of tetraazacycloalkane derivatives
US5410043A (en) Process for the production of mono-N-substituted tetraaza macrocycles
JP3105259B2 (en) Method for producing 1-amino-1,2,3-triazole
JP4299677B2 (en) Method for producing combretastatin
JP3471836B2 (en) Method for producing mono-N-substituted tetraazacyclododecane derivative and -tetradecane derivative, and method for producing metal complex for diagnosis and treatment
WO2006000836A1 (en) Process for the preparation of anastrozole
US6759555B2 (en) Process for the preparation of combretastatins
HU216444B (en) Process for preparation of phenylacetic acid derivatives
ES2912409T3 (en) Intermediates and processes for the preparation of linagliptin and its salts
EP2231627B1 (en) New process for the synthesis of moguisteine
WO2016115962A1 (en) Preparation method for nebivolol intermediate and preparation method for nebivolol
CZ397A3 (en) Process for preparing derivatives of o-chloromethylphenylglycoxylic acid
EP0612740B1 (en) Methods of producing pantothenic acid derivative and its starting materials for producing the same
JP2002275155A (en) Method for producing cyclic amine derivative
JP5019691B2 (en) Process for the preparation of decahydro-2a, 4a, 6a, 8a-tetraazacyclopenta [fg] acenaphthylene and functionalized derivatives
JPWO2003068745A1 (en) Method for producing 2,3-diaminopyridine derivative

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired